SHIVALIK RASAYAN ; Shivalik Rasayan Limited has successfully filed Drug Master File (DMF) for Avapritinib API with USFDA for which the Complete Assessment (CA) has been done. It is used to treat Gastrointestine Stromal Tumors (GIST).

It is a product of Sanofi and is marketed under brand name of "Ayvakit". Ayvakit achieved a revenue of 700 million USD during 2025

SHIVALIK RASAYAN LIMITED